Check patentability & draft patents in minutes with Patsnap Eureka AI!

Application of Sonidegib in preparation of medicine for treating ankylosing spondylitis

A technology of sonidegib, 1.sonidegib, applied in the field of application of sonidegib in the preparation of drugs for the treatment of ankylosing spondylitis

Inactive Publication Date: 2021-08-27
NANJING UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is no report about the therapeutic effect of autoimmune diseases, especially ankylosing spondylitis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Sonidegib in preparation of medicine for treating ankylosing spondylitis
  • Application of Sonidegib in preparation of medicine for treating ankylosing spondylitis
  • Application of Sonidegib in preparation of medicine for treating ankylosing spondylitis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] 1. Pharmacological experiment of Sonidegib: conditional knockout (CD4-Cre; SHP2 f / f ) mouse spontaneous ankylosing spondylitis model (as recorded in CN106177999B)

[0022] SHP2 on C57BL / 6 background f / f and CD4-Cre; SHP2 f / f Female mice were kept in an SPF grade animal room at 21±2°C, with free access to water and food, and alternated day and night for 12 hours. At the age of 7 months, they were randomly divided into two groups. The control group was given solvent control, and the treatment group was given 100 mg / kg sonidegib by intragastric administration. The mice were administered for 4 months, and the symptoms of bone lesions in the mice were monitored in real time. At present, the treatment drugs for ankylosing spondylitis still focus on anti-inflammatory treatment, including non-steroidal anti-inflammatory drugs, TNF-α antibody and IL-17 blocking factor. None of the existing drugs can significantly improve the symptoms of ectopic bone formation and osteoarthri...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of pharmacy. According to the application of the Sonidegib in preparation of the medicine for treating the ankylosing spondylitis, aiming at an SHP2 conditional knockout (CD4-Cre; SHP2f / f) mouse spontaneous ankylosing spondylitis-like bone lesion model, the sonidegib can effectively improve symptoms such as ectopic osteogenesis, articular bone fusion and osteoporosis of a mouse.

Description

technical field [0001] The invention relates to a new application of Sonidegib, an inhibitor of Smoothened (SMO), in particular to the application of sonidegib in the preparation of medicines for treating ankylosing spondylitis. Background technique [0002] The Smo inhibitor Sonidegib inhibits cell survival and proliferation by inhibiting the hedgehog signaling pathway, and is mainly used clinically for the treatment of tumors. Sonidegib induces cell arrest and apoptosis in glioblastoma, prostate cancer, and renal cell carcinoma cells. In July 2015, the FDA approved sonidegib for the treatment of locally advanced basal cell carcinoma that has recurred after surgery or radiation therapy. There is no report about the therapeutic effect of autoimmune diseases, especially ankylosing spondylitis. This study mainly found that sonidegib has an effect on conditional knockout (CD4-Cre; SHP2 f / f ) significantly improved the spontaneous ankylosing spondylitis-like bone lesions in m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/5377A61P19/08A61P29/00A61P19/10A61P19/02
CPCA61K31/5377A61P19/08A61P29/00A61P19/10A61P19/02
Inventor 孙洋徐强邵粉丽
Owner NANJING UNIV
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More